Real�6�2Drug Technology Co., Ltd is a computational drug�6�2discovery company focused on turning early discovery into clinical success. We build AI�6�2driven screening tools that look beyond single�6�2endpoint “activity” to the multi�6�2dimensional attributes that make real medicines work in patients. Our flagship product, 5FMDL screener, operationalizes a five�6�2dimension Maximum Drug Likeness (5F�6�2MDL) strategy to prioritize candidates that align with approved drugs across physicochemical developability, pharmacokinetics, efficacy, safety, and stability. We collaborate with academic and industry partners to accelerate hit identification and de�6�2risk lead optimization, with an initial focus on anti�6�2infective discovery against drug�6�2resistant pathogens. Rigor, transparency, and reproducibility guide our model development and validation, and our tools are designed to integrate into standard CADD workflows. Unless specified, our software is for research use only.